Skip to main content
Frontiers in Molecular Biosciences logoLink to Frontiers in Molecular Biosciences
. 2024 Oct 8;11:1497296. doi: 10.3389/fmolb.2024.1497296

Corrigendum: Comprehensive analysis of the prognostic and immunological role of PAFAH1B in pan-cancer

Yixiao Yuan 1,, Xiulin Jiang 2,, Lin Tang 1,, Juan Wang 1, Lincan Duan 1,*
PMCID: PMC11493683  PMID: 39439529

In the published article, there was an error in Figure 12 as published. The representative pictures of transwell, SMCC-7721 cells in Figure 12G were presented incorrectly. The corrected Figure 12 and its caption appear below.

FIGURE 12.

FIGURE 12

Knockdown of PAFAH1B3 inhibits LIHC progression. (A) The expression PAFAH1B3 in LIHC cells lines was examined by qRT-PCR assay. (B) Establishment of PAFAH1B3 knockdown cell lines in SMC-7721 and Hu7 verified by qRT-PCR assay. (C) Knockdown of PAFAH1B3 dramatically inhibits SMC-7721 and Hu7 cells proliferation examined by growth curve assay. (D, E) Knockdown of PAFAH1B3 dramatically inhibits SMC-7721 and Hu7 cells colony formation ability. (F, G) Knockdown of PAFAH1B3 dramatically inhibits SMC-7721 and Hu7 cells migration and invasion abilities.

The authors apologize for this error and state that this does not change the scientific conclusions of the article in any way. The original article has been updated.

Publisher’s note

All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article, or claim that may be made by its manufacturer, is not guaranteed or endorsed by the publisher.


Articles from Frontiers in Molecular Biosciences are provided here courtesy of Frontiers Media SA

RESOURCES